ArticleBMC cancer2023

PD-1 inhibitors combined with paclitaxel and cisplatin in first-line treatment of esophageal squamous cell carcinoma (ESCC): a network meta-analysis.

Jia Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.